BAUSCH + LOMB receives FDA clearance for vitrectomy cutter
Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced that the U.S. Food and Drug Administration granted 510(k) clearance for its Bi-Blade+ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
